Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05355753
Title A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors C4 Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Sarcoma Oncology Research Center Santa Monica California 90403 United States Details
University of Colorado - Aurora Cancer Center Aurora Colorado 80045 United States Details
Mayo Clinic - Jacksonville Jacksonville Florida 32224 United States Details
University of Iowa Hospital and Clinics Iowa City Iowa 52242 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Mayo Clinic - Rochester Rochester Minnesota 55905 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center New York New York 10021 United States Details
Columbia University New York New York 10027 United States Details
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field